MetLife Investment Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $206K | Buy |
|
|||||
|
2025
Q1 | $169K | Sell |
|
|||||
|
2024
Q4 | $266K | Buy |
|
|||||
|
2024
Q3 | $204K | Sell |
|
|||||
|
2024
Q2 | $211K | Buy |
|
|||||
|
2024
Q1 | $455K | Sell |
|
|||||
|
2023
Q4 | $1.29M | Hold |
|
|||||
|
2023
Q3 | $1.1M | Hold |
|
|||||
|
2023
Q2 | $1.75M | Buy |
|
|||||
|
2023
Q1 | $1.51M | Buy |
|
|||||
|
2022
Q4 | $964K | Hold |
|
|||||
|
2022
Q3 | $684K | Hold |
|
|||||
|
2022
Q2 | $521K | Buy |
|
|||||
|
2022
Q1 | $946K | Buy |
|
|||||
|
2021
Q4 | $1.42M | Hold |
|
|||||
|
2021
Q3 | $1.77M | Hold |
|
|||||
|
2021
Q2 | $2.42M | Buy |
|
|||||
|
2021
Q1 | $2.22M | Sell |
|
|||||
|
2020
Q4 | $1.86M | Hold |
|
|||||
|
2020
Q3 | $709K | Buy |
|
|||||
|
2020
Q2 | $225K | Hold |
|
|||||
|
2020
Q1 | $200K | Buy |
|
|||||
|
2019
Q4 | $253K | Sell |
|
|||||
|
2019
Q3 | $345K | Hold |
|
|||||
|
2019
Q2 | $404K | Buy |
|
|||||
|
2019
Q1 | $417K | Hold |
|
|||||
|
2018
Q4 | $427K | Hold |
|
|||||
|
2018
Q3 | $312K | Sell |
|
|||||
|
2018
Q2 | $209K | Hold |
|
|||||
|
2018
Q1 | $120K | Buy |
|
|||||
|
2017
Q4 | $35K | Buy |
|